ATE209189T1 - 1-arylsulfonyl-3-phenyl-1,4,5,6- tetrahydropyridazinen - Google Patents

1-arylsulfonyl-3-phenyl-1,4,5,6- tetrahydropyridazinen

Info

Publication number
ATE209189T1
ATE209189T1 AT93917006T AT93917006T ATE209189T1 AT E209189 T1 ATE209189 T1 AT E209189T1 AT 93917006 T AT93917006 T AT 93917006T AT 93917006 T AT93917006 T AT 93917006T AT E209189 T1 ATE209189 T1 AT E209189T1
Authority
AT
Austria
Prior art keywords
pct
group
chch
radical
proviso
Prior art date
Application number
AT93917006T
Other languages
English (en)
Inventor
Donald W Combs
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Application granted granted Critical
Publication of ATE209189T1 publication Critical patent/ATE209189T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650905—Six-membered rings having the nitrogen atoms in the positions 1 and 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicinal Preparation (AREA)
AT93917006T 1992-07-01 1993-07-01 1-arylsulfonyl-3-phenyl-1,4,5,6- tetrahydropyridazinen ATE209189T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90698492A 1992-07-01 1992-07-01
US8098693A 1993-06-21 1993-06-21
PCT/US1993/006394 WO1994001412A1 (en) 1992-07-01 1993-07-01 1-arylsulphonyl, arylcarbonyl and 1-arylphosphonyl-3-phenyl-1,4,5,6-tetrahydropyridazines

Publications (1)

Publication Number Publication Date
ATE209189T1 true ATE209189T1 (de) 2001-12-15

Family

ID=26764215

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93917006T ATE209189T1 (de) 1992-07-01 1993-07-01 1-arylsulfonyl-3-phenyl-1,4,5,6- tetrahydropyridazinen

Country Status (14)

Country Link
US (1) US5684151A (de)
EP (1) EP0650480B1 (de)
JP (1) JPH07508987A (de)
AT (1) ATE209189T1 (de)
AU (1) AU668206B2 (de)
BR (1) BR9306661A (de)
CA (1) CA2139307A1 (de)
DE (1) DE69331196T2 (de)
DK (1) DK0650480T3 (de)
ES (1) ES2168276T3 (de)
HU (1) HUT68424A (de)
NZ (1) NZ254534A (de)
PT (1) PT650480E (de)
WO (1) WO1994001412A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4430755A1 (de) * 1994-08-30 1996-03-07 Boehringer Mannheim Gmbh Neue Phosphanoxide, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
US5707985A (en) * 1995-06-07 1998-01-13 Tanabe Seiyaku Co. Ltd. Naphthyl-, quinolyl- and isoquinolyl- sulfonamide derivatives as cell adhesion modulators
DE19632549A1 (de) * 1996-08-13 1998-02-19 Merck Patent Gmbh Arylalkanoylpyridazine
DE19723722A1 (de) * 1997-05-30 1998-12-10 Schering Ag Nichtsteroidale Gestagene
US6107295A (en) * 1997-08-01 2000-08-22 Merck Patent Gesellschaft Mit Beschrankter Haftung Arylalkanoyl pyridazines
DE19850701A1 (de) 1998-11-04 2000-05-11 Merck Patent Gmbh Benzoylpyridazine
US7253169B2 (en) 1999-11-12 2007-08-07 Gliamed, Inc. Aza compounds, pharmaceutical compositions and methods of use
US6417189B1 (en) 1999-11-12 2002-07-09 Gpi Nil Holdings, Inc. AZA compounds, pharmaceutical compositions and methods of use
DE10064997A1 (de) * 2000-12-23 2002-06-27 Merck Patent Gmbh Benzoylpyridazine
ES2350113T3 (es) * 2004-04-14 2011-01-18 Amgen Inc. Arilsulfonas y usos relacionados con las mismas.
MY150763A (en) 2006-10-24 2014-02-28 Repros Therapeutics Inc Compositions and methods for suppressing endometrial proliferation
US20090170823A1 (en) * 2007-12-20 2009-07-02 Duramed Pharmaceuticals, Inc. Dosage Regimens and Pharmaceutical Compositions and Packages for Emergency Contraception
TWI539953B (zh) 2008-04-28 2016-07-01 瑞波若斯治療學公司 用於治療乳癌之組成物和方法
MX2012010327A (es) 2010-03-22 2012-11-16 Repros Therapeutics Inc Composiciones y metodos para la administracion no toxica de antiprogestinas.
JOP20200024A1 (ar) 2017-08-04 2020-02-02 Bayer Ag مركبات ثنائي هيدروكساديازينون
EP3661917B1 (de) * 2017-08-04 2022-05-11 Bayer Aktiengesellschaft 6-((3-trifluoromethyl)phenyl)-4,5-dihydropyridazin-3(2h)-on-derivate als pde3a and pde3b inhibitoren zur behandlung von krebs
AU2020215088A1 (en) 2019-02-01 2021-07-22 Bayer Aktiengesellschaft 1,2,4-triazin-3(2H)-one compounds for the treatment of hyperproliferative diseases

Also Published As

Publication number Publication date
JPH07508987A (ja) 1995-10-05
AU4667093A (en) 1994-01-31
AU668206B2 (en) 1996-04-26
NZ254534A (en) 1997-12-19
HU9403841D0 (en) 1995-02-28
BR9306661A (pt) 1998-12-08
PT650480E (pt) 2002-03-28
ES2168276T3 (es) 2002-06-16
DK0650480T3 (da) 2002-05-13
EP0650480B1 (de) 2001-11-21
HUT68424A (en) 1995-06-28
EP0650480A1 (de) 1995-05-03
CA2139307A1 (en) 1994-01-20
WO1994001412A1 (en) 1994-01-20
US5684151A (en) 1997-11-04
DE69331196D1 (de) 2002-01-03
DE69331196T2 (de) 2002-07-25

Similar Documents

Publication Publication Date Title
DE69331196D1 (de) 1-arylsulfonyl-3-phenyl-1,4,5,6-tetrahydropyridazinen
IL74031A (en) 6-(4-(n-cyanoguanidino)phenyl)-4,5-dihydro-3(2h)-pyridazinone derivatives,their preparation and pharmaceutical compositions containing them
ATE168101T1 (de) Arylpyridazinone
ES8604854A1 (es) Un procedimiento para la preparacion de un compuesto coulante para el tenido del cabello por oxidacion.
CA2159817A1 (en) Pyrimidine Acyclonucleoside Derivatives
SE8503466L (sv) Aminofenolforeningar
ES2000779A6 (es) Un procedimiento para preparar derivados de piridazinona y metodo para reprimir plagas de insectos usando dichos derivados.
AU560607B2 (en) Pyridazinones their preparation and use and medicaments containing pyridazinones
MXPA04002838A (es) Derivados de alquilaminopiridazinona sustituidos, procedimiento para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
DK0847384T3 (da) Carbamoylcarboxylsyreamider
TW198680B (de)
ZA938414B (en) Substituted ortho-ethenylphenylacetic acid derivatives
TW334340B (en) Preparation for pyrazolyl derivatives
AU558254B2 (en) Imidazolecarboxylic acid derivatives as cardiotonics
ATE42957T1 (de) Waessrige kristallsuspension von steroidglykoestern.
DK0395527T3 (da) Imidazobenzodiazepiner og deres salte, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og præparater med indhold deraf
NZ216922A (en) 6-amino-androsta-1,4-diene-3,17-dione derivatives and pharmaceutical compositions
ZA965409B (en) Iminooxybenzyl compounds, their preparation and their use.
DE3467297D1 (en) Benzobicyclononane amino derivatives with anticonvulsive properties
DK0651747T3 (da) Carbostyrilderivater